By Colin Kellaher
Thermo Fisher Scientific Inc. Monday said its fiscal second-quarter revenue will exceed expectations, bolstered by sales aimed at supporting the global response to the coronavirus pandemic.
The Waltham, Mass., company said it expects reported and organic revenue growth of about 10% for the quarter ended June 27.
The company in mid-May had said it expected second-quarter organic revenue would be flat to down 10%, but it noted that results could fall outside that range due to uncertainty in the marketplace.
Thermo Fisher Monday said strong global sales of PCR-based tests and other products and services supporting the Covid-19 response contributed more than $1.4 billion of revenue in the second quarter.
Analysts polled by FactSet, on average, were expecting the company to report quarterly sales of $5.82 billion, down from $6.32 billion a year earlier.
Write to Colin Kellaher at email@example.com